Annette Bicher

575 total citations
16 papers, 437 citations indexed

About

Annette Bicher is a scholar working on Reproductive Medicine, Oncology and Cancer Research. According to data from OpenAlex, Annette Bicher has authored 16 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Reproductive Medicine, 7 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Annette Bicher's work include Ovarian cancer diagnosis and treatment (8 papers), Genetic factors in colorectal cancer (4 papers) and Cancer Genomics and Diagnostics (3 papers). Annette Bicher is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Genetic factors in colorectal cancer (4 papers) and Cancer Genomics and Diagnostics (3 papers). Annette Bicher collaborates with scholars based in United States and Ukraine. Annette Bicher's co-authors include Eddie Reed, Elise C. Kohn, Patricia Anne Davis, Debra O. Adamo, Gisele Sarosy, Steven M. Steinberg, Frederick P. Ognibene, Robert E. Cunnion, Michaele C. Christian and E Reed and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Annette Bicher

16 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annette Bicher United States 9 212 194 118 103 67 16 437
Yasunori Hashiguchi Japan 14 229 1.1× 196 1.0× 236 2.0× 73 0.7× 88 1.3× 37 549
Erin K. Crane United States 13 195 0.9× 205 1.1× 109 0.9× 126 1.2× 161 2.4× 38 535
C O'Flaherty United States 6 187 0.9× 149 0.8× 127 1.1× 117 1.1× 57 0.9× 8 430
Mark Crozier United States 7 185 0.9× 251 1.3× 94 0.8× 84 0.8× 105 1.6× 10 435
Congwei Jia China 13 223 1.1× 138 0.7× 202 1.7× 107 1.0× 59 0.9× 63 564
D. Paraïso France 14 272 1.3× 401 2.1× 149 1.3× 216 2.1× 203 3.0× 35 689
Deanna Teoh United States 12 173 0.8× 400 2.1× 253 2.1× 120 1.2× 193 2.9× 20 708
W. ten Bokkel Huinink Netherlands 10 154 0.7× 200 1.0× 87 0.7× 190 1.8× 57 0.9× 17 414
Mojca Persic United Kingdom 6 147 0.7× 167 0.9× 103 0.9× 38 0.4× 64 1.0× 12 345
Karen Theilade Denmark 6 160 0.8× 201 1.0× 77 0.7× 146 1.4× 66 1.0× 7 388

Countries citing papers authored by Annette Bicher

Since Specialization
Citations

This map shows the geographic impact of Annette Bicher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Bicher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Bicher more than expected).

Fields of papers citing papers by Annette Bicher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette Bicher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Bicher. The network helps show where Annette Bicher may publish in the future.

Co-authorship network of co-authors of Annette Bicher

This figure shows the co-authorship network connecting the top 25 collaborators of Annette Bicher. A scholar is included among the top collaborators of Annette Bicher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Bicher. Annette Bicher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gruber, Daniel D., et al.. (2020). Urinary symptoms in women receiving carboplatin/paclitaxel for treatment of gynecologic cancers. International Journal of Gynecological Cancer. 30(9). 1418–1423. 4 indexed citations
2.
Maxwell, G. Larry, et al.. (2014). Metastatic Choriocarcinoma Presenting in a Gravid Woman. Gynecologic and Obstetric Investigation. 79(4). 276–279. 2 indexed citations
3.
Coleman, Robert L., Annette Bicher, Donald Richards, et al.. (2010). Efficacy and safety of farletuzumab, a humanized monoclonal antibody to folate receptor alpha, in platinum-sensitive relapsed ovarian cancer subjects: Final data from a multicenter phase II study.. Journal of Clinical Oncology. 28(15_suppl). 5001–5001. 20 indexed citations
4.
Bicher, Annette, Gisele Sarosy, Elise C. Kohn, et al.. (2010). Age does not influence taxol dose intensity in recurrent carcinoma of the ovary. Cancer. 71(S2). 594–600. 5 indexed citations
5.
Coleman, R., Annette Bicher, Darlene Gibbon, et al.. (2009). 8000 Efficacy and safety of farletuzumab, a humanized monoclonal antibody to folate receptor alpha, in platinum-sensitive relapsed ovarian cancer subjects: preliminary data from a phase-2 study. European Journal of Cancer Supplements. 7(2). 450–450. 3 indexed citations
6.
Bicher, Annette, Robert L. Coleman, Darlene Gibbon, et al.. (2008). Exploratory phase II efficacy study of MORAb-003, a monoclonal antibody against folate receptor alpha, in platinum-sensitive ovarian cancer in first relapse. Journal of Clinical Oncology. 26(15_suppl). 5500–5500. 25 indexed citations
7.
Ueland, F., Annette Bicher, Don S. Dizon, et al.. (2006). A randomized phase II trial with gemcitabine with or without pertuzumab (rhuMAb 2C4) in platinum-resistant ovarian cancer (OC): Preliminary safety data. Journal of Clinical Oncology. 24(18_suppl). 13001–13001. 3 indexed citations
8.
Yu, Jing, et al.. (2000). Absence of evidence for allelic loss or allelic gain for ERCC1 or for XPD in human ovarian cancer cells and tissues. Cancer Letters. 151(2). 127–132. 9 indexed citations
9.
Reed, Eddie, Christa S. Zerbe, Otis W. Brawley, Annette Bicher, & Seth M. Steinberg. (2000). Analysis of Autopsy Evaluations of Ovarian Cancer Patients Treated at the National Cancer Institute, 1972–1988. American Journal of Clinical Oncology. 23(2). 107–116. 37 indexed citations
10.
Bicher, Annette, et al.. (1997). Loss of Heterozygosity in Human Ovarian Cancer on Chromosome 19q. Gynecologic Oncology. 66(1). 36–40. 42 indexed citations
11.
Bicher, Annette, et al.. (1995). Ovarian Malignant Mixed Müllerian Tumors Treated With Platinum–Based Chemotherapy. Obstetrics and Gynecology. 85(5, Part 1). 735–739. 39 indexed citations
12.
Bicher, Annette, Ayşegül A. Şahin, & Thomas W. Burke. (1994). Metastatic Cervical Cancer Presenting as Cholecystitis. Gynecologic Oncology. 54(2). 250–253. 5 indexed citations
13.
Kohn, Elise C., Gisele Sarosy, Annette Bicher, et al.. (1994). Dose-Intense Taxol: High Response Rate in Patients With Platinum-Resistant Recurrent Ovarian Cancer. JNCI Journal of the National Cancer Institute. 86(1). 18–24. 152 indexed citations
14.
Bicher, Annette, et al.. (1994). Flexible granulocyte colony-stimulating factor dosing in ovarian cancer patients who receive dose-intense taxol therapy. Blood. 83(5). 1188–1192. 15 indexed citations
15.
Bicher, Annette, Elise C. Kohn, Gisele Sarosy, et al.. (1993). The absence of cumulative bone marrow toxicity in patients with recurrent adenocarcinoma of the ovary receiving dose-intense taxol and granulocyte colony stimulating factor. Anti-Cancer Drugs. 4(2). 141–148. 8 indexed citations
16.
Reed, Eddie, R. J. Parker, Annette Bicher, et al.. (1993). Platinum-DNA adduct in leukocyte DNA of a cohort of 49 patients with 24 different types of malignancies.. PubMed. 53(16). 3694–9. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasunori Hashiguchi Breakdown of academic impact, for papers by Erin K. Crane Breakdown of academic impact, for papers by C O'Flaherty Breakdown of academic impact, for papers by Mark Crozier Breakdown of academic impact, for papers by Congwei Jia Breakdown of academic impact, for papers by D. Paraïso Breakdown of academic impact, for papers by Deanna Teoh Breakdown of academic impact, for papers by W. ten Bokkel Huinink Breakdown of academic impact, for papers by Mojca Persic Breakdown of academic impact, for papers by Karen Theilade
Rankless by CCL
2026